Synthetics Biologics Stock News

ROCKVILLE, Md., Feb. 8, 2022 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that VCN Biosciences, S.L.''s (VCN) VCN-01 received Orphan Drug…

Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT ) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH ) shares climbed 62.5% to close at $19.50 following its recent listing on NASDAQ. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL ) surged 51.4% to settle at $1.62. Kaival Brands Innovations recently announced the U.S. Court of Appeals for the Eleventh Circuit has granted a judicial stay of the marketing denial order previously issued by the FDA to Bidi Vapor in September 2021. Origin Agritech Limited (NASDAQ: SEED ) gained 34.5% to settle at $6.39 after the company said it expects FY22 sales to exceed RMB150 million. Bakkt Holdings, Inc. (NASDAQ: BKKT ) shares jumped 34% to close at $5.80. Luokung Technology Corp. (NASDAQ: LKCO ) gained 24.3% to close at $0.63. Luokung recently announced the receipt of Nasdaq notification regarding minimum bid price deficiency. Navidea Biopharmaceuticals, Inc. (NYSE: NAVB ) surged 23.2% to settle at $0.8870 after the company announced a research agreement with the University of Pennsylvania evaluating Tc99m tilmanocept as a prognostic marker for glioblastoma.

Synthetic Biologics Inc. (SYN) shares closed today at 2.0% above its 52 week low of $0.26, giving the company a market cap of $36M. The stock is currently up 2.3% year-to-date, down 68.2% over the past 12 months, and down 99.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 55.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 258.5% The company's stock price performance over the past 12 months lags the peer average by -729.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Synthetic Biologics Inc. (SYN) shares closed 1.0% lower than its previous 52 week low, giving the company a market cap of $37M. The stock is currently down 25.7% year-to-date, down 31.8% over the past 12 months, and down 98.9% over the past five years. This week, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 57.6% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -265.3% The company's stock price performance over the past 12 months lags the peer average by -296.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Synthetic Biologics Inc. (SYN) shares closed today at 1.6% above its 52 week low of $0.28, giving the company a market cap of $37M. The stock is currently down 26.6% year-to-date, down 24.1% over the past 12 months, and down 98.9% over the past five years. This week, the Dow Jones Industrial Average rose 2.1%, and the S&P 500 rose 2.1%. Trading Activity Trading volume this week was 18.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -252.9% The company's stock price performance over the past 12 months lags the peer average by -235.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Synthetic Biologics Inc. (SYN) shares closed 4.1% lower than its previous 52 week low, giving the company a market cap of $39M. The stock is currently down 21.7% year-to-date, down 17.6% over the past 12 months, and down 98.9% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 8.4% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -234.8% The company's stock price performance over the past 12 months lags the peer average by -203.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Staffing 360 Solutions, Inc. (NASDAQ:STAF) with the stream of 4.39% also noticed, India Synthetic Biologics, Inc. (AMEX:SYN) encountered a rapid change of 1.18% in the last hour of Thursdays trading The post Razzle-dazzle Stock: Staffing 360 Solutions, Inc. (NASDAQ:STAF), Synthetic Biologics, Inc. (AMEX:SYN) appeared first on Stocks Equity .

Synthetic Biologics Inc. (AMEX:SYN) shares, rose in value on Thursday, 12/16/21, with the stock price down by -0.19% to the previous days close as strong demand from buyers drove the stock to $0.32. Actively observing the price movement in the last trading, the stock closed the session at $0.32, falling within a range of $0.30 Is Synthetic Biologics Inc. (AMEX) Bullish Or Bearish In 2021? Read More »

Synthetic Biologics, Inc. (NYSEAMERICAN:SYN) was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 493,700 shares, a growth of 139.1% from the November 15th total of 206,500 shares. Based on an average daily volume of 1,680,000 shares, the days-to-cover ratio is []

Synthetic Biologics, Inc. (NYSEAMERICAN:SYN) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 493,700 shares, a growth of 139.1% from the November 15th total of 206,500 shares. Currently, 0.4% of the shares of the stock are short sold. Based on an average trading []

The trading price of Synthetic Biologics Inc. (AMEX:SYN) closed lower on Monday, December 13, closing at $0.31, -4.30% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Fishtailing stocks: Trevena, Inc. (NASDAQ:TRVN -2.67%), Synthetic Biologics, Inc. (AMEX:SYN -5.07%) appeared first on Stocks Equity .

Synthetic Biologics Inc. (AMEX:SYN) traded at $0.34 at close of the session on Monday, 11/29/21, made an upward move of 0.88% on its previous days price. Looking at the stock we see that its previous close was $0.34 and the beta (5Y monthly) reads 1.86 with the days price range being $0.34 $0.36. In Synthetic Biologics Inc. (AMEX:SYN) Slides 0.88 Percent In Recent Trade, What Can We Expect Next? Read More »

T2 Biosystems, Inc. (TTOO) with the stream of 5.33% also noticed, India Synthetic Biologics, Inc. (SYN) encountered a rapid change of 6.45% in the last hour of Wednesday’s trading session. … The post Flaming Stock: T2 Biosystems, Inc. (NASDAQ:TTOO), Synthetic Biologics, Inc. (AMEX:SYN) appeared first on Stocks Equity .